• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿霉素和顺铂在人乳中的排泄情况。

Doxorubicin and cisplatin excretion into human milk.

作者信息

Egan P C, Costanza M E, Dodion P, Egorin M J, Bachur N R

出版信息

Cancer Treat Rep. 1985 Dec;69(12):1387-89.

PMID:4075315
Abstract

Plasma and milk concentrations of doxorubicin (DOX) and cisplatin were measured after iv administration of these agents to a lactating patient with ovarian cancer. Cisplatin was undetectable in human milk. Milk concentrations of DOX often exceeded those detected in concomitant plasma samples. For DOX, the highest milk:plasma concentration ratio was 4.43:1 and was observed 24 hours after administration of the drug. The area under concentration versus time curve (AUC) for DOX was approximately the same in plasma and milk. Doxorubicinol was the major metabolite of DOX in plasma and in milk. The AUC for doxorubicinol was ten times higher in milk than in plasma. However, the total amount of anthracycline antibiotic delivered in the milk (maximum concentration of active anthracycline antibiotic: 0.24 mg/L) was negligible.

摘要

在给一名患有卵巢癌的哺乳期患者静脉注射阿霉素(DOX)和顺铂后,测定了血浆和乳汁中这两种药物的浓度。人乳中未检测到顺铂。阿霉素的乳汁浓度常常超过同期血浆样本中的浓度。对于阿霉素,最高的乳汁与血浆浓度比为4.43:1,在给药后24小时观察到该比值。阿霉素的浓度-时间曲线下面积(AUC)在血浆和乳汁中大致相同。阿霉素醇是血浆和乳汁中阿霉素的主要代谢产物。阿霉素醇的AUC在乳汁中比在血浆中高10倍。然而,乳汁中递送的蒽环类抗生素总量(活性蒽环类抗生素的最大浓度:0.24 mg/L)可忽略不计。

相似文献

1
Doxorubicin and cisplatin excretion into human milk.阿霉素和顺铂在人乳中的排泄情况。
Cancer Treat Rep. 1985 Dec;69(12):1387-89.
2
Phase I pharmacokinetic study of cyclosporin A combined with doxorubicin.环孢素A联合阿霉素的I期药代动力学研究
Cancer Res. 1993 Oct 15;53(20):4837-42.
3
[Pharmacokinetics study of intraperitoneal cisplatin in ovarian carcinoma].[顺铂腹腔内给药在卵巢癌中的药代动力学研究]
Zhonghua Fu Chan Ke Za Zhi. 1993 Apr;28(4):224-6, 254.
4
[Pharmacokinetic study of intraperitoneal chemotherapy with high-dose cisplatin for advanced ovarian cancer].[大剂量顺铂腹腔化疗治疗晚期卵巢癌的药代动力学研究]
Zhonghua Fu Chan Ke Za Zhi. 1996 Mar;31(3):159-62.
5
cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.顺式二氯(2-甲基吡啶)氨铂(II)(AMD473),一种新型空间位阻铂配合物:小鼠体内活性、毒理学及药代动力学
Clin Cancer Res. 1997 Nov;3(11):2063-74.
6
A novel doxorubicin-glucuronide prodrug DOX-GA3 for tumour-selective chemotherapy: distribution and efficacy in experimental human ovarian cancer.一种用于肿瘤选择性化疗的新型阿霉素-葡萄糖醛酸前药DOX-GA3:在实验性人类卵巢癌中的分布与疗效
Br J Cancer. 2001 Feb;84(4):550-7. doi: 10.1054/bjoc.2000.1640.
7
ICON 2 and ICON 3 data in previously untreated ovarian cancer: results to date.ICON 2和ICON 3研究中既往未接受治疗的卵巢癌数据:迄今的结果。
Semin Oncol. 1997 Oct;24(5 Suppl 15):S15-23-S15-25.
8
Disposition of total and free cisplatin on two consecutive treatment cycles in patients with ovarian cancer.
Cancer Chemother Pharmacol. 1987;19(1):75-9. doi: 10.1007/BF00296261.
9
Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.低剂量阿霉素及其代谢产物在艾滋病相关卡波西肉瘤患者中的药代动力学
Cancer Chemother Pharmacol. 2005 May;55(5):488-96. doi: 10.1007/s00280-004-0900-4. Epub 2005 Feb 23.
10
[Pharmacokinetic profile of high-dose doxorubicin administered during a 6 h intravenous infusion in breast cancer patients].[乳腺癌患者6小时静脉输注高剂量阿霉素的药代动力学特征]
Bull Cancer. 1997 Jun;84(6):603-8.

引用本文的文献

1
Mitochondria-derived reactive oxygen species induce over-differentiation of neural stem/progenitor cells after non-cytotoxic cisplatin exposure.线粒体衍生的活性氧在非细胞毒性顺铂暴露后诱导神经干/祖细胞过度分化。
Front Cell Dev Biol. 2025 Apr 29;13:1555153. doi: 10.3389/fcell.2025.1555153. eCollection 2025.
2
Transporters and drug secretion into human breast milk.转运蛋白与药物向人母乳中的分泌。
Expert Opin Drug Metab Toxicol. 2025 Apr;21(4):409-428. doi: 10.1080/17425255.2025.2461479. Epub 2025 Feb 7.
3
First-in-human pharmacokinetics of tamoxifen and its metabolites in the milk of a lactating mother: a case study.
首例人乳中他莫昔芬及其代谢物的药代动力学:病例研究。
ESMO Open. 2020 Oct;5(5):e000859. doi: 10.1136/esmoopen-2020-000859.
4
Duration of cisplatin excretion in breast milk.顺铂在母乳中的排泄持续时间。
J Hum Lact. 2013 Nov;29(4):469-72. doi: 10.1177/0890334413479671. Epub 2013 Mar 14.
5
Cancer chemotherapy during pregnancy. Consortium of cancer in pregnancy evidence.孕期癌症化疗。孕期癌症联盟证据。
Can Fam Physician. 2001 Jan;47:41-2.
6
Pharmacokinetic changes during pregnancy and their clinical relevance.孕期的药代动力学变化及其临床意义。
Clin Pharmacokinet. 1997 Nov;33(5):328-43. doi: 10.2165/00003088-199733050-00002.
7
Pharmacokinetics of anticancer drugs in children.儿童抗癌药物的药代动力学
Clin Pharmacokinet. 1987 Mar;12(3):168-213. doi: 10.2165/00003088-198712030-00002.
8
Drugs in human milk. Clinical pharmacokinetic considerations.母乳中的药物。临床药代动力学考量
Clin Pharmacokinet. 1988 Apr;14(4):217-40. doi: 10.2165/00003088-198814040-00003.
9
Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).新生儿药物生物处置的原则。药代动力学-药效学界面的批判性评价(第一部分)。
Clin Pharmacokinet. 1988 Apr;14(4):189-216. doi: 10.2165/00003088-198814040-00001.
10
Clinical pharmacokinetics of doxorubicin.阿霉素的临床药代动力学
Clin Pharmacokinet. 1988 Jul;15(1):15-31. doi: 10.2165/00003088-198815010-00002.